Neurogene (NGNE) Earnings Date & Reports

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning)... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NGNE is expected to report earnings to rise 28.57% to -135 cents per share on November 23

Q3'26

Est.

$-1.35

Q2'26

Beat

by $0.38

Q1'26

Missed

by $0.12

Q4'25

Beat

by $0.13

Q3'25

Beat

by $0.19

The last earnings report on August 11 showed earnings per share of -104 cents, beating the estimate of -142 cents. With 258.60K shares outstanding, the current market capitalization sits at 773.04M.

View a ticker or compare two or three

NGNE

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days